EYPT - EyePoint Pharmaceuticals Inc. (EYPT) CEO Nancy Lurker on Q2 2021 Results - Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (EYPT) Q2 2021 Earnings Conference Call August 04, 2021 08:30 AM ET Company Participants George Elston - Chief Financial Officer & Head, Corporate Development Nancy Lurker - President & Chief Executive Officer Jay Duker - Chief Strategic Scientific Officer Scott Jones - Chief Commercial Officer Conference Call Participants Jennifer Kim - Cantor Fitzgerald Georgi Yordanov - Cowen and Company Yatin Suneja - Guggenheim Partners Yi Chen - H.C. Wainwright Yale Jen - Laidlaw Andrew D'Silva - B. Riley Securities Presentation Operator Good morning. My name is Norma and I'll be your conference operator today. At this time, I would like to welcome everyone to EyePoint Pharmaceuticals' Second Quarter 2021 Financial Results and Recent Corporate Developments Conference Call. There will be a question-and-answer session to follow at the conclusion of the prepared remarks. Please be advised that the call is being recorded at the company's request. I would
For further details see:
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q2 2021 Results - Earnings Call Transcript